Oncology Clinical Research Medical Director — Remote

Sumitomo Pharma; Concord (NH); Remote; USD 226,000 - 282,000; Full time

Benefits offered by this job

401(k) plan

Medical, dental, vision insurance

Generous time off and holidays

Job summary

Sumitomo Pharma Co., Ltd. is seeking an Associate Medical Director in Oncology for the planning, execution and management of clinical studies. You will build relationships with investigators and key opinion leaders and contribute to regulatory filings.

The role emphasizes hematologic malignancies, collaboration across global teams, and leadership of cross-functional study efforts, with a strong focus on safety, efficacy, and scientific integrity.

Qualifications

• MD or DO degree and board eligibility.
• Residency completion preferred.
• Experience in hematologic malignancies or solid tumors desirable.
• 0–3 years pharmaceutical drug development experience required.

Responsibilities

• Design and oversight of clinical study protocols.
• Provide clinical input to regulatory documents and investigator interactions.
• Lead clinical study teams and review safety/efficacy data.
• Collaborate with academic investigators and KOLs.
• Author clinical sections for INDs/NDAs and related filings.
• Coordinate with Drug Safety & Pharmacovigilance.
• Present at scientific, medical, and regulatory meetings.
• Maintain high level of disease area knowledge via literature and conferences.

Skills

Hematology oncology knowledge

Leadership abilities

Regulatory compliance

Communication skills

Scientific collaboration

Education

MD/DO or non-US equivalent

Residency completed

Subspecialty fellowship desirable

Experience with blood cancers or solid tumors desirable

Pharmaceutical drug development experience 0–3 years

Tools

Regulatory writing tools

Job description

Sumitomo Pharma Co., Ltd. is seeking an Associate Medical Director in Oncology for the planning, execution and management of clinical studies. You will build relationships with investigators and key opinion leaders and contribute to regulatory filings.

The role emphasizes hematologic malignancies, collaboration across global teams, and leadership of cross-functional study efforts, with a strong focus on safety, efficacy, and scientific integrity.